Fusion Antibodies Plc (FAB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2023 | 09-2022 | 03-2022 | 09-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 195 | 1,198 | 2,049 | 1,987 | 2,686 |
| Inventories | 538 | 552 | 585 | 562 | 480 |
| Other current assets | 954 | 1,489 | 1,648 | 1,881 | 1,539 |
| TOTAL | $1,687 | $3,239 | $4,282 | $4,430 | $4,705 |
| Non-Current Assets | |||||
| PPE Net | 375 | 743 | 633 | 941 | 1,123 |
| Intangibles | 0 | 0 | 0 | 1 | 2 |
| TOTAL | $375 | $743 | $633 | $942 | $1,125 |
| Total Assets | $2,062 | $3,982 | $4,915 | $5,372 | $5,830 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 480 | 1,057 | 466 | 954 | 344 |
| TOTAL | $879 | $1,140 | $1,208 | $1,082 | $996 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 20 | 270 | 20 | 44 | 20 |
| TOTAL | $60 | $270 | $23 | $44 | $87 |
| Total Liabilities | $939 | $1,410 | $1,231 | $1,126 | $1,083 |
| Shareholders' Equity | |||||
| Common Shares | 1,040 | 1,040 | 1,040 | 1,037 | 1,024 |
| Retained earnings | -7,564 | -6,115 | -5,003 | -4,402 | -3,824 |
| TOTAL | $1,123 | $2,572 | $3,684 | $4,246 | $4,747 |
| Total Liabilities And Equity | $2,062 | $3,982 | $4,915 | $5,372 | $5,830 |